REBIF 8.8 micrograms, solution for injection in a pre-filled syringe / rebif 22 microgrammes, solution for injection in a pre-filled syringe 6 syringes of 0.2 ml
Active ingredients: Interferon beta-1a
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection6 syringes of 0.2 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- REBIF 8,8 microgrammes, solution injectable en seringue préremplie / REBIF 22 microgrammes, solution injectable en seringue préremplie
- Pharmaceutical form
- solution injectable et solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 6 seringue(s) préremplie(s) en verre de 0,2 ml avec aiguille(s) acier - 6 seringue(s) préremplie(s) en verre de 0,5 ml avec aiguille(s) acier
- Marketing authorisation holder
- MERCK SERONO EUROPE (ROYAUME-UNI)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 24 Oct 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a specialist
- Renewal by a specialist only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66975533CIP73759027CIP133400937590273Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| INTERFÉRON BÊTA-1Asolution à 22 microgrammes | 22 microgrammes · une seringue pré-remplie (0,5 ml) | SA |
| INTERFÉRON BÊTA-1Asolution à 8,8 microgrammes | 8,8 microgrammes · une seringue pré-remplie (0,2 ml) | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.